S
Sarepta Therapeutics, Inc.
SRPT · NASDAQ · Healthcare · 1.9B
Closing price
$17.85
-1.98% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.6×
Enterprise value / EBITDAEV/EBITDA
-3.3×
Free cash flow yieldFCF yield
-16.4%
Return on equityROE
-62.5%
Operating margin
-29.9%
Net debt / EBITDAbalance-sheet strength
-0.4×
Interest coverage
-67.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.